Edition:
United Kingdom

Mersana Therapeutics Inc (MRSN.OQ)

MRSN.OQ on NASDAQ Stock Exchange Global Select Market

8.02USD
19 Oct 2018
Change (% chg)

$-0.29 (-3.49%)
Prev Close
$8.31
Open
$8.34
Day's High
$8.71
Day's Low
$8.01
Volume
15,166
Avg. Vol
50,058
52-wk High
$23.67
52-wk Low
$7.79

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 4.19 -0.538
Mar '18 3.06 -0.544
FY 2017 Dec '17 3.26 -0.613
Sep '17 6.27 -0.340
Jun '17 3.73 -0.394
Mar '17 4.29 -0.356
FY 2016 Dec '16 12.00 0.056
Sep '16 3.26 -0.258
Jun '16 6.22 -0.166
Mar '16 3.70 -0.237
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 6 4.48 6.50 3.00 --
Quarter Ending Mar-19 2 4.85 5.50 4.20 --
Year Ending Dec-18 6 15.77 18.30 13.00 20.45
Year Ending Dec-19 6 20.79 27.00 16.76 35.45
Earnings (per share)
Quarter Ending Dec-18 6 -0.62 -0.51 -0.73 -0.10
Quarter Ending Mar-19 2 -0.55 -0.51 -0.59 --
Year Ending Dec-18 6 -2.30 -2.07 -2.43 -2.12
Year Ending Dec-19 6 -2.31 -2.05 -2.55 -1.72
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.41 33.64
P/E High - Last 5 Yrs. -- 287.36 45.19
P/E Low - Last 5 Yrs. -- 89.75 23.75
Beta -- 0.93 0.88
Price to Sales (TTM) -- 124.37 5.83
Price to Book (MRQ) -- 15.29 4.89
Price to Tangible Book (MRQ) 18.86 14.52 6.51
Price to Cash Flow (TTM) -- 70.10 22.92
% Owned Institutions 78.13 14.25 2.14

Dividends

  Company industry sector
Dividend Yield -- 0.33 1.51
Dividend Yield - 5 Year Avg -- 0.24 1.52
Dividend 5 Year Growth Rate -- 2.54 5.40
Payout Ratio(TTM) -- 16.75 43.85

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.57 8.10
Sales (TTM) vs TTM 1 Yr. Ago -- 103.65 5.80
Sales - 5 Yr. Growth Rate -- 30.74 9.87
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 24.06 23.38
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 37.62 10.92
Capital Spending - 5 Yr. Growth Rate -- 38.52 14.87

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.95 2.25
Current Ratio (MRQ) 2.53 5.36 3.05
LT Debt to Equity (MRQ) 0.00 34.93 12.76
Total Debt to Equity (MRQ) 0.00 36.74 17.18
Interest Coverage (TTM) -- -96.75 37.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.09 54.87
Gross Margin - 5 Yr. Avg. -- 49.02 52.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -579.09 11.01
Operating Margin (TTM) -- -786.66 4.07
Operating Margin - 5 Yr. Avg. -- -600.20 6.34
Pre-Tax Margin (TTM) -- -748.77 5.12
Pre-Tax Margin - 5 Yr. Avg. -- -605.79 6.78
Net Profit Margin (TTM) -- -749.75 1.39
Net Profit Margin - 5 Yr. Avg. -- -608.47 3.03
Effective Tax Rate (TTM) -- 23.52 23.24
Effective Tax Rate - 5 Yr. Avg. -- 18.69 24.16

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,677,535 808,218,600
Net Income/Employee (TTM) -- 1,703,754 95,058,584
Receivable Turnover (TTM) -- 20.77 5.78
Inventory Turnover (TTM) -- 2.37 3.63
Asset Turnover (TTM) -- 0.40 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -1.39 10.90
Return on Assets - 5 Yr. Avg. -- 3.03 12.01
Return on Investment (TTM) -- 0.21 14.27
Return on Investment - 5 Yr. Avg. -- 2.10 15.60
Return on Equity (TTM) -- 1.17 15.99
Return on Equity - 5 Yr. Avg. -- 2.74 16.87
  1 Year 3 Year 5 Year
Sales % 142.99 -- --
EPS (TTM) % 16.61 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Mersana Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 6.92 3.23 64 58
13 Week 42.40 35.47 85 61
26 Week -- -- -- 76
52 Week -- -- -- 47
YTD -- -- -- 59
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 82.91%
# of Holders: 85
Total Shares Held: 19,196,279
3 Mo. Net Change: -5,916
# New Positions: 0
# Closed Positions: 2
# Increased Positions: 5
# Reduced Positions: 6
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.